Ceptaris Therapeutics' Series B Round

Ceptaris Therapeutics raised a round of funding on November 17, 2006.

Ceptaris Therapeutics, formerly Yaupon Therapeutics, is developing a gel formulation of mechlorethamine hydrochloride (mechlorethamine) for the treatment of early stage (stages I-IIA) mycosis fungoide…

Articles about Ceptaris Therapeutics' Series B Round: